This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merz Pharma Gmbh & Co. Kgaa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jens Neubauer and His Patent in Hyaluronic Acid Innovation.
Introduction
Jens Neubauer is an inventor associated with Glauburg, Germany, and Merz Pharma GmbH & Co. KGaA. His patent work concerns a modified hyaluronic acid derivative designed for preparing crosslinked hydrogels for aesthetic applications.
Latest Patents
Neubauer is associated with 1 patent: “Aldehyde-modified hyaluronic acid, method for preparing same and applications thereof.” The invention describes modifying the —CH₂—OH group of the N-acetyl-D-glucosamine unit in hyaluronic acid to an aldehyde group with the structure —CH₂—O—CH₂—CHO. The degree of modification ranges from 1.0% to 15.0%. The derivative is prepared by reacting glycerol-modified hyaluronic acid with an oxidizing agent, such as periodate, and is intended for use in crosslinked hydrogels for aesthetic applications.
Career Highlights
Neubauer’s listed patent reflects work on the chemical modification of hyaluronic acid and its potential application in aesthetic products. His company affiliation is Merz Pharma GmbH & Co. KGaA.
Collaborations
Patrick Plitt and Sibylle Mueller are identified as Neubauer’s coworkers. Their names provide context for his professional network, though the supplied information does not specify their roles in the patent.
Conclusion
Jens Neubauer’s patent focuses on aldehyde-modified hyaluronic acid, a material designed to support crosslinked hydrogel development for aesthetic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile